Home Equities Score Here is all you need to know about recent AzurRx BioPharma Inc...

Here is all you need to know about recent AzurRx BioPharma Inc (AZRX) stock performance

AzurRx BioPharma Inc. (AZRX) shares gained 3.06% to trade at $0.87 in after-market on Friday, April 23, 2021. Earlier, AZRX’s stock gained 0.98% to close Friday’s session at $0.84. AZRX shares have surged 44.04% over the last 12 months, and they have moved up by 6.35% in the past week. Over the past three months, the stock has lost54.12%, while over the past six months, it has added 2.33%.

Let’s check out its recent news.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

CEO letter to AZRX shareholders

On April 15, 2021, the President, Chief Executive Officer, and Chairman of AzurRx BioPharma, Inc issued a letter to its shareholders explaining the company’s corporate and clinical achievements during the first quarter of 2021.

   Read More

Agreement with PPD to manage Clinical trial

On April 13, 2021, AzurRx BioPharma Inc. signed an agreement with PPD Inc to carry out its Phase 1b/2a clinical trial evaluating proprietary formulations of micronized niclosamide for grade 1 colitis and diarrhea in oncology patients receiving treatment with immune checkpoint inhibitors (ICIs).

Commencing Phase 2 RESERVOIR trial

On April 6, 2021, AzurRx BioPharma Inc commenced the Phase 2 RESERVOIR trial evaluating oral formulation of micronized niclosamide (FW-1022) for the treatment of COVID-19 related gastrointestinal (GI) infections. The data will be available in Q 1 2022.

The Phase 2 trial is to examine the safety and efficacy of FW-1022 and the objectives of the trial are to confirm the safety of niclosamide and demonstrate efficacy in clearing the SARS-CoV-2 virus from the GI tract.

Phase 2 clinical trial results of MS1819

On March 31, 2021, AzurRx BioPharma Inc reported results from its Phase 2b OPTION 2 clinical trial investigating MS1819 in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI).

MS1819 study did not consistently meet the primary efficacy endpoint but it demonstrated to be safe and well-tolerated.

enteric capsule formulation is the leading cause of the drug’s uneven efficacy performance lies with the enteric capsule formulation according to the company.

The registered direct offering of AZRX common stock

On March 08, 2021, AzurRx BioPharma Inc announced the sale of 7,858,548 shares of common stock and warrants at $1.2725 per share and accompanying warrant in a registered direct offering priced at the market under Nasdaq rules.

The warrants have an exercise price of $1.21 per share and will expire five years following the date of issuance.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

There is no prominent news in the last week and AZRX is still testing its lead candidate. There was no such recent activity behind its positive trend on Friday and it’s hard to say how it will start the new trading week on Monday.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

Fastly, Inc. (NYSE: FSLY) stock plunged in the pre-market trading session: here’s why

Fastly, Inc. (NYSE: FSLY), a company specializing to provide real-time content delivery network services, which offers edge cloud platform, edge software development kit (SDK),...

What Is The Reason For GreenBox (GBOX) Stock Rallying In Pre-Market?

In premarket trading hours, GreenBox POS (NASDAQ: GBOX) rose 5.34% to $11.24 on the last check Thursday. GreenBox stock gained 1.81% to close at...

Why Is The HOME Stock Getting Raised In Pre-Hour Trades?

At last check, shares of At Home Group Inc. (NYSE: HOME) were up 14.90 percent to trade at $36.01 in premarket session today. The...

What Caused Nemaura (NMRD) To Rise Today In Premarket Session?

The shares of Nemaura Medical Inc. (NASDAQ: NMRD) were trading 12.12% higher at $12.4 before the bell at last check. Nemaura stock closed the...

Luokung Technology Corp. (LKCO) Stock Surges Amid China-U.S. Economic Tensions

Luokung Technology Corp. (LKCO) stock prices were down by 8.64% as of the market closing on May 5th, 2021, bringing the price per share...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.